The stock's fall snapped a two-day winning streak.

The company also offers platform-agnostic next-generation sequencing tests and a suite of sample prep and thermal cycling instruments.

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle ...

A research team with Professor Neha Kamat used synthetic liposomes and bacterial extracts to generate immune responses ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

DXC Technology Co. closed 42.37% below its 52-week high of $24.83, which the company reached on November 8th.